Is the prescription being skipped?
Under US federal law checked on September 26, 2026, a prescription medicine needs a prescription from someone legally allowed to write it.
Who may prescribe depends on state rules; possibilities include a doctor, physician assistant or nurse practitioner. The last two are health professionals who may assess patients and prescribe. Ask for their name and license details, along with their job title.
If the offer leaves out that prescription step, stop considering it. A payment screen is not an assessment.
Is a pharmacy-made drug being called approved?
A compounded preparation gets no FDA approval. FDA stands for the agency’s name: Food and Drug Administration.
In guidance checked September 26, 2026, FDA warns against presenting a compounded product as an approved generic or claiming equal results have been clinically proved.
Can anyone answer after it arrives?
FDA’s telehealth checklist flags missing access to a licensed doctor after delivery, damaged packaging, spelling mistakes on labels and suspect pharmacy details.
Ask who handles a problem and how to reach them. If the pharmacy’s name is unclear, get that answer before going further.
Does the label name the product clearly?
FDA has found fraudulent compounded semaglutide with invented pharmacy names, as well as labels using real pharmacies’ names without their involvement.
A low price or a smart photograph cannot answer who assessed you or who supplied the medicine. Keep those questions separate from how inviting the offer looks.